Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: Evaluation of a nurse-oriented management approach

Canadian Journal of Cardiology

Volumn 17, Issue 2, 2001, Pages 169-175

  Baillargeon, J P ^a   Lepage, S ^a   Larrivee L ^a   Roy, M A ^a   Landry, S ^a   Maheux, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Health care delivery; Health outcomes; Hypercholesterolemia; Myocardial infarction

Indexed keywords

ANTILIPEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; COST CONTROL; DRESSLER SYNDROME; DYSLIPIDEMIA; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MASS SCREENING; NURSE PATIENT RELATIONSHIP; OUTCOMES RESEARCH; PRACTICE GUIDELINE; RECURRENCE RISK; SECONDARY PREVENTION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANTILIPEMIC AGENTS; CHOLESTEROL, LDL; FEMALE; HUMANS; HYPERLIPIDEMIAS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0035060239     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
4. Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: Forecasting the incremental benefits of preventing coronary and cerebrovascular events
5. Cost-effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: Life table method applied to health authority population
6. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
7. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease
8. Secondary prevention practices after acute myocardial infarction in a large city hospital
9. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease
10. After 4S, CARE and LIPID: Is evidence-based medicine being practised?
11. An overview of randomized trials of rehabilitation with exercise after myocardial infarction
12. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk
13. A case-management system for coronary risk factor modification after acute myocardial infarction
14. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP)
15. Management of hypercholesterolemia: Practice patterns for primary care providers and cardiologists
16. Cardiac rehabilitation: The forgotten intervention
17. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and other dyslipidemias
18. Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease
19. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: A randomized, controlled trial
20. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
21. Primary care outcomes in patients treated by nurse practitioners or physicians: A randomized trial
22. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
23. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease
24. Management of lipid disorders in the elderly
25. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years
26. Cholesterol in the elderly: Is it important?
27. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction
28. Changes in plasma cholesterol levels after hospitalization for acute coronary events
29. Serum cholesterol concentration before and after streptokinase in acute myocardial infarction
30. Discontinuation of antihyperlipidemic drugs
31. Persistence of use of lipid-lowering medications: A cross-national study